LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 75 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $358,000 | +188.7% | 85,425 | +171.2% | 0.22% | +260.7% |
| Q4 2019 | $124,000 | -71.4% | 31,498 | -36.1% | 0.06% | -75.3% |
| Q3 2019 | $434,000 | +112.7% | 49,300 | +124.1% | 0.25% | +118.6% |
| Q2 2019 | $204,000 | -66.8% | 22,000 | -77.0% | 0.11% | -67.1% |
| Q1 2019 | $615,000 | – | 95,607 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |